GlobeNewswire: Aura Health Inc. Contains the last 10 of 6 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T18:29:33ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/04/17/1806013/0/en/Aura-Health-Announces-5-82-Million-Closing-of-the-Second-Tranche-of-Its-Subscription-Receipt-Offering-and-Share-Exchange-Transaction.html?f=22&fvtc=4&fvtv=49777Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Transaction2019-04-17T19:29:55Z<![CDATA[NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.]]>https://www.globenewswire.com/news-release/2019/02/27/1743686/0/en/Aura-Health-Announces-Closing-of-1-9-Million-on-the-First-Tranche-of-Subscription-Receipt-Financing.html?f=22&fvtc=4&fvtv=49777Aura Health Announces Closing of $1.9 Million on the First Tranche of Subscription Receipt Financing2019-02-27T18:42:25Z<![CDATA[NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.]]>https://www.globenewswire.com/news-release/2019/02/22/1740917/0/en/Aura-Health-Provides-Further-Clarity-Regarding-Offering-and-Strategic-Investor.html?f=22&fvtc=4&fvtv=49777Aura Health Provides Further Clarity Regarding Offering and Strategic Investor2019-02-22T16:01:21Z<![CDATA[NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.]]>https://www.globenewswire.com/news-release/2018/08/22/1555064/0/en/Aura-Enters-Into-Agreement-to-Acquire-Majority-Interest-in-Israeli-Cannabis-Company.html?f=22&fvtc=4&fvtv=49777Aura Enters Into Agreement to Acquire Majority Interest in Israeli Cannabis Company2018-08-22T12:00:00Z<![CDATA[TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the "Company" or “Aura”) (CSE: BUZZ) is very pleased to announce it has entered into a binding letter of intent (“LOI”) to subscribe to an unsecured convertible note (“Convertible Note”) in Holycanna Ltd. (“Holycanna”), an Israel-based company with an cultivation and sales license application (“License Application”) submitted to the Israeli Ministry of Health (“Yakar”). Upon approval of the License Application, the Company’s Convertible Note will automatically convert to a majority (54%) equity stake in Holycanna.]]>https://www.globenewswire.com/news-release/2018/08/16/1553056/0/en/Aura-announces-appointment-of-new-chief-executive-officer.html?f=22&fvtc=4&fvtv=49777Aura announces appointment of new chief executive officer2018-08-16T13:23:40Z<![CDATA[TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the "Company" or “Aura”) (CSE:BUZZ) is very pleased to announce the appointment of Daniel Cohen to the role of Chief Executive Officer (CEO), effective immediately. Former CEO Chris Carl will continue to serve in his role as President and Corporate Secretary for Aura while Mr. Cohen assumes the role of CEO. Mr. Cohen has nearly 20 years of experience in the capital markets and most previously served as a partner and head of institutional equity sales at Beacon Securities. Prior to that, he held roles in institutional equity sales, investment banking and equity research at Wellington West Capital Markets, RBC Capital Markets and HSBC Securities. Mr. Cohen holds an MBA in Finance from McGill University and is a CFA Charterholder.]]>https://www.globenewswire.com/news-release/2018/08/10/1550504/0/en/Aura-Health-Announces-Closing-of-RTO-Transaction.html?f=22&fvtc=4&fvtv=49777Aura Health Announces Closing of RTO Transaction2018-08-10T21:25:29Z<![CDATA[TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the "Corporation"), formerly Lamêlée Iron Ore Ltd., is pleased to announce that it completed on August 9, 2018 its previously announced reverse take-over transaction (the "RTO Transaction") with Aura Health Corp. ("Aura"). Aura is a Toronto based company that has investments in four operating medical marijuana patient assessment clinics in Arizona, Nevada and Florida.]]>